Ana Jaklenec
- Molecular Biology top 5%
- Biomedical Engineering top 2%
- Immunology top 5%
- Biomaterials top 1%
- Pharmaceutical Science top 0.5%
- Co-authors
- Róbert LangerKevin J. McHughMatthias A. OberliDaniel BlankschteinAndreas M. ReichmuthAdam M. BehrensAaron C. AnselmoDaniel G. Anderson
- Topics
- RNA Interference and Gene Delivery (14 papers)Advanced Drug Delivery Systems (14 papers)Immunotherapy and Immune Responses (8 papers)
- Partner nations
- United StatesChinaIsrael
In The Last Decade
Ana Jaklenec
47 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Molecular Biology 1.8k
- Biomedical Engineering 1.2k
- Immunology 779
- Biomaterials 713
- Pharmaceutical Science 598
Countries citing papers authored by Ana Jaklenec
This map shows the geographic impact of Ana Jaklenec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Jaklenec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Jaklenec more than expected).
Fields of papers citing papers by Ana Jaklenec
This network shows the impact of papers produced by Ana Jaklenec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Jaklenec. The network helps show where Ana Jaklenec may publish in the future.
Co-authorship network of co-authors of Ana Jaklenec
This figure shows the co-authorship network connecting the top 25 collaborators of Ana Jaklenec. A scholar is included among the top collaborators of Ana Jaklenec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Jaklenec. Ana Jaklenec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 13 | |
| 7 | 18 | |
| 8 | 25 | |
| 9 | 134 | |
| 10 | Stimuli-responsive transdermal microneedle patchesbreakdown → | 219 |
| 11 | 78 | |
| 12 | 45 | |
| 13 | 174 | |
| 14 | 50 | |
| 15 | 86 | |
| 16 | 80 | |
| 17 | 114 | |
| 18 | 158 | |
| 19 | 113 | |
| 20 | 17 |
About Ana Jaklenec
Ana Jaklenec is a scholar working on Pharmaceutical Science, Molecular Medicine and Immunology, having authored 52 papers that have together received 3.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Advanced Drug Delivery Systems (14 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Pharmaceutical Science (598 citations), Biomaterials (713 citations) and Immunology (779 citations). Ana Jaklenec has collaborated with scholars based in United States, China and Israel. Frequent co-authors include Róbert Langer, Kevin J. McHugh, Matthias A. Oberli, Daniel Blankschtein, Andreas M. Reichmuth, Adam M. Behrens, Aaron C. Anselmo, Daniel G. Anderson, Michael J. Mitchell and J. Robert Dorkin. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.